POM-V Prescription Required

Metaxx 15 mg/ml Oral Suspension for Horses

Active ingredient: Meloxicam

Form

Liquid

Species

Horses

Manufacturer

Alfasan Nederland B.V.

VMD MA No.

36408/5009

What it's used for

Alleviation of inflammation and relief of pain in both acute and chronic musculo- skeletal disorders in horses.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Metaxx 15 mg/ml Oral Suspension for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of inflammation and relief of pain in both acute and chronic musculo-
skeletal disorders in horses.

Do not use in pregnant or lactating mares.
Do not use in horses suffering from gastrointestinal disorders such as irritation
and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients. Do not use in horses less than 6 weeks of age.

Diarrhoea, typically associated with NSAIDs, was very rarely observed in
clinical trials. The clinical sign was reversible.Loss of appetite, lethargy,
abdominal pain, colitis and urticaria have been reported very rarely from post-
marketing safety experience.
Anaphylactoid reactions, which may be serious (including fatal), have been
observed very rarely from post-marketing safety experience and should be
treated symptomatically.
If adverse reactions occur, treatment should be discontinued and the advice of
a veterinarian should be sought.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse
reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals
treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated
reports).

Issued: January 2023
AN: 01565/2021

None.

Issued: January 2023
AN: 01565/2021

i). Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is
a potential risk of renal toxicity.
ii). Special precautions to be take by the person administering the veterinary
medicinal product to animals
Meloxicam and other non-steroidal anti-inflammatory drugs (NSAIDs) may
cause hypersensitivity (allergic reactions). People with known hypersensitivity to
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the
veterinary medicinal product.
Avoid oral exposure, including hand-to-mouth contact. Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
This veterinary medicinal product can cause eye irritation. In case of contact
with the eyes, immediately rinse thoroughly with water.
Meloxicam may have adverse effects on pregnancy and/or embryofoetal
development. Avoid dermal exposure including hand-to-mouth contact.
Pregnant women or women attempting to conceive should wear impermeable
gloves when administering the veterinary medicinal product.

Do not administer concurrently with glucocorticoids, other non-steroidal anti-
inflammatory drugs or with anticoagulant agents.

This veterinary medicinal product does not require any special storage
conditions.

Excipient:
Sodium benzoate (E211) 1.5 mg
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.